Weightwatchers International Inc.

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: North America, United Kingdom, Continental Europe and Other. The North America segment consists of United States and Canada company-owned operations. The United Kingdom segment includes United Kingdom company-owned operations. The Continental Europe segment consists of Germany, Switzerland, France, Spain, Belgium, Netherlands, and Sweden company-owned operations. The others segment offers Australia, New Zealand company-owned operations, as well as revenues and costs from franchises in the United States. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Weight Watchers to Lead Clinical Weight Management with Strategic Acquisitions

Weight Watchers International is confident in its ability to return to a growth trajectory by providing science-based solutions for weight management. The company's strategic acquisitions, enhanced marketing approach, and product enhancements position it well for future success in the weight management industry.

Weight Watchers beats Q1 targets, eyes growth through digital

Weight Watchers International's Q1 2023 performance exceeded expectations with strong subscriber growth and revenue results.
The company's focus on digital expansion, data-informed culture, and strategic acquisitions positions it well for future growth.
Challenges include intensifying competition, sustaining growth amidst lower marketing spend, and successful integration of acquisitions.
Opportunities lie in enhancing member experience, expanding in the clinical space, and leveraging brand equity for efficient growth.

WeightWatchers reports subscriber growth despite revenue challenges and supply shortages

WeightWatchers International is navigating challenges in revenue due to clinical supply shortages but is focusing on core business growth and member engagement. The company's strategic focus on weight health leadership and synergies between its core and clinical businesses present opportunities for growth and innovation.

Weight Watchers reports strong Q3 performance, eyes growth opportunities

Weight Watchers International (WW) delivered a strong performance in Q3, with notable subscriber growth, revenue, and margin expansion. The company's strategic focus on innovation, partnerships, and cost efficiency underpins its resilience and market competitiveness.
While facing challenges such as supply constraints and uncertainties in future guidance, Weight Watchers remains committed to sustainable growth through subscriber-centric strategies and operational agility. Opportunities lie in expanding Clinical offerings, targeted programs, and industry engagement.
Overall, Weight Watchers' Q3 earnings call highlights its financial strength, strategic direction, and commitment to driving subscriber growth and engagement. The company's performance underscores its ability to adapt, innovate, and navigate challenges in the competitive landscape.

Weight Watchers focuses on health, sees growth in subscribers

Weight Watchers International Inc. is prioritizing growth in clinical subscribers and subscription revenue, focusing on enhancing digital products, and differentiating itself through science and brand equity. The company is confident in delivering year-over-year growth in various key metrics for 2024.

WeightWatchers International Inc. reports strong Q1 performance and strategic growth initiatives

WeightWatchers International Inc. delivered a strong performance in Q1 2024, showcasing growth in clinical business, record margins, and strategic initiatives to drive long-term growth. While facing challenges in marketing strategy shifts and restructuring costs, the company is well-positioned to capitalize on opportunities in subscriber ARPU stabilization, B2B partnerships, and product enhancements.

WeightWatchers anticipates growth amidst challenges, emphasizes cost-saving measures

WeightWatchers International faces short-term challenges but remains optimistic about its financial performance for the year. The company is implementing cost-saving measures, focusing on strategic growth initiatives, and emphasizing the importance of expanding access and care options.

WeightWatchers reports Q3 revenue decline but focuses on growth

WeightWatchers International is navigating challenges while leveraging strengths to drive growth and operational efficiency.
The company's focus on innovation, brand revitalization, and cost savings aligns with long-term growth objectives.
Despite market dynamics, WeightWatchers remains optimistic about future demand and committed to strategic initiatives for turnaround.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Novo Nordisk

Yes, Oprah Winfrey is in the news again — in this case, for her decision to sell her stake in WW International WW, +8.33% (formerly known as WeightWatchers) and leave the company's board. The decision came after Winfrey announced, to considerable backlash, that she was taking a weight-loss drug to help her in her longtime battle to lose some pounds and keep them off, in addition to hiking, drinking plenty of water and other methods.

Can we cut Oprah Winfrey some slack? The struggle to lose weight is real — and drugs can be a lifesaver.

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced that it will present at the following investor conference.

WW International, Inc. to Present at the Morgan Stanley Technology, Media & Telecom Conference

Oprah Winfrey will not seek re-election to WW's board of directors later this year. The celebrity reports she is using a weight-loss drug to manage her weight, posing a potential conflict of interest.

What Weighed WW International Down So Much Today

Shares of WW International (NASDAQ: WW ) stock are plunging lower after the weight loss and fitness company reported its fourth-quarter earnings. WW also revealed that Oprah Winfrey has decided not to seek re-election as director of the company.

5 Investors Betting Big on Weight Watchers (WW) Stock as Oprah Backs Out

WeightWatchers' parent company Weight Watchers International flopped over 27% in pre-market Thursday trades after chat show icon Oprah Winfrey announced her departure from the board. Winfrey, who has been on the board since 2015, will not stand for re-election in WeightWatcehrs' upcoming annual meeting in May.

WeightWatchers' shares flop after Oprah Winfrey announces board departure

WW International, Inc. (WW) Q4 2023 Earnings Call Transcript

The weight-management-services company said that Winfrey is also selling her stock in WW to donate the funds to the National Museum of African American History and Culture.

WW International Says Oprah Winfrey Won't Stand for Re-Election to Board

Shares of WW International Inc., better known as Weight Watchers, tumbled after hours on Wednesday, as the weight-loss platform said Oprah Winfrey planned to leave its board and donate her stake in the company after revealing that she used a weight-loss drug.

Oprah's departure from Weight Watchers' board is the latest bad news for the stock, amid weight-loss drug frenzy

Continued Collaboration to Advocate for and Elevate Conversation on Weight Health Ms. Winfrey to Donate Financial Interest in WeightWatchers to the National Museum of African American History and Culture NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) announced today that Director Oprah Winfrey has decided not to stand for re-election at the Company's upcoming annual meeting of shareholders to be held in May 2024.

WW International, Inc. Announces Upcoming Oprah Winfrey Board Transition

Fourth Quarter 2023 End of Period Subscribers of 3.8 million, including 67 thousand End of Period Clinical Subscribers Revenues of $206.0 million Gross margin of 60.6%; excluding the net impact of restructuring charges, adjusted gross margin of 61.4% Operating Loss of $6.0 million; excluding the net impact of restructuring charges and non-cash intangible impairment charges, adjusted operating income of $21.3 million Full Year Fiscal 2023 Revenues of $889.6 million Gross margin of 59.5%; excluding the net impact of restructuring charges, adjusted gross margin of 61.9% Operating Income of $22.3 million; excluding the net impact of restructuring charges, acquisition transaction costs, and non-cash intangible impairment charges, adjusted operating income of $89.5 million Company Provides Full Year Fiscal 2024 Guidance NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the fourth quarter and full year fiscal 2023. “2023 was a pivotal year as we began transforming our business for the future.

WW International, Inc. Announces Fourth Quarter and Full Year 2023 Results

Investors shouldn't discount the influence of Oprah Winfrey. Weight Watchers' shift to prescribing GLP-1 drugs could pay off.

Weight Watchers Stock: Buy, Sell, or Hold?

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the fourth quarter and full year 2023 after market close on Wednesday, February 28, 2024.

WW International, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call

NEW YORK and BURLINGTON, N.C., Feb. 07, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) today announced that Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is deepening its existing partnership with WeightWatchers for Business to offer their full-spectrum weight health platform, with individualized pathways of both behavioral and clinical interventions, available at no cost to Labcorp's U.S. employees. Spouses and domestic partners covered under a Labcorp medical plan are also eligible.

Labcorp Elevates Employee Health Benefits with WeightWatchers for Business Full-Spectrum Weight Health Platform

Cazoo Group Ltd

Mobileye Global Inc

Pinduoduo Inc - ADR

Tesla

The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.

Top 5 Consumer Stocks That Could Blast Off In Q1

WW International had a fantastic year in 2023, but things are off to a catastrophic start in 2024. Eli Lilly's launch of a new service to offer weight-loss drugs poses a big threat to WeightWatchers.

WW International Stock Has Lost Nearly Half Its Value in Just 1 Month: Is It a Bargain or a Bust?

WW International stock has been hammered as consumers flock to new miracle weight loss drugs from big pharma. Downloads of the company's weight loss app are down less than 50% -- but the company's stock price is down more than 50%.

Why WW International Stock Bounced 6% Higher Today

Short-seller Cedar Grove argues that WeightWatchers can't win in a GLP-1 world. The stock has fallen sharply this year after Eli Lilly announced a new telehealth service.

Why WeightWatchers Stock Took a Dive Again Today

NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) today announced the findings of its “ Beyond Hunger: Understanding Food Noise ” report focusing on people living with overweight or obesity and their experience of constant rumination about food, known as “food noise.” In partnership with STOP Obesity Alliance at George Washington University's Redstone Global Center for Prevention and Wellness , the study reveals a deeper understanding of food noise, which may reflect a biological contribution to obesity, and brings it to the forefront of the cultural conversation around weight bias, GLP-1 medications, and Weight Health.

WeightWatchers Unveils “Beyond Hunger: Understanding Food Noise” Report Offering Insights Into the Experience of Ongoing, Intrusive Thoughts About Food

A prognosticator sounded a warning about the weight loss specialist. He noted that competition is increasing, and traditional dieting methods are declining in popularity.

Why WW International Stock Plummeted by 9% Today

In the Big Pharma space, weight-loss-related drugs are gaining a lot of attention. Accordingly, for investors attempting to gauge the impact of these drugs on certain businesses, there's a clear bifurcation building in the market.

Why Is WeightWatchers (WW) Stock Down 5% Today?

Powerful healthcare company Eli Lilly introduced a new e-commerce platform that will surely boost sales of its new weight loss drug. Investors fear this will put a real dent in WW International's business.

Why WW International Stock Was Sinking Fast This Week

Eli Lilly stock just announced a new online service for obtaining prescriptions and ordering weight loss drugs. WW stock is reacting negatively to the news.

Why WW International Stock Just Dropped 11%

Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication and WW International Inc. NYSE: WW (WeightWatchers) principles of nutrition and exercise.

Weight Watchers gains from Oprah's GLP-1 weight-loss

Options bears are blasting WW International (WW) today, with 2,010 puts exchanged so far – double the intraday average volume – compared to just 995 calls. Most active is the January 2024 7.50-strike call, but positions are currently opening at the 9.50-strike put in that series.

Bears Target Heavily Shorted WW International Stock

WeightWatchers launches a new program dedicated to helping people who have jumped on the weight-loss drug bandwagon. The program is called the GLP-1 Program.

News for Weightwatchers International Inc. Stock (WW)